Wockhardt shines on getting approval to raise funds upto Rs 150 crore
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Wockhardt is currently trading at Rs. 529.90, up by 23.60 points or 4.66% from its previous closing of Rs. 506.30 on the BSE.
The scrip opened at Rs. 509.00 and has touched a high and low of Rs. 547.70 and Rs. 509.00 respectively. So far 314894 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 569.80 on 31-Dec-2020 and a 52 week low of Rs. 211.00 on 19-May-2020.
Last one week high and low of the scrip stood at Rs. 547.70 and Rs. 435.00 respectively. The current market cap of the company is Rs. 5727.39 crore.
The promoters holding in the company stood at 72.12%, while Institutions and Non-Institutions held 3.19% and 24.69% respectively.
Wockhardt’s the Credit Facilities Committee of the Board of Directors, at its meeting held on April 21, 2021, has approved the raising of funds upto Rs 150 crore through issuance of Rated, Unlisted, Secured Non-Convertible Debentures on private placement basis, in one or more tranches/series to such eligible investors as maybe deemed appropriate.
Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.
